Inspire Medical Systems, Inc. to Present at the Stifel 2022 Healthcare Conference
Get Alerts INSP Hot Sheet
Join SI Premium – FREE
MINNEAPOLIS, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022 at the Lotte New York Palace Hotel in New York, NY.
Inspire is scheduled to present at 2:25 p.m. Eastern Time. The presentation will be accessible via a live webcast at: https://wsw.com/webcast/stifel74/register.aspx?conf=stifel74&page=insp&url=https://wsw.com/webcast/stifel74/insp/2113108
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical SystemsInspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media ContactEzgi YagciVice President, Investor Relations[email protected]617-549-2443
Source: Inspire Medical Systems
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Inspire Medical Systems (INSP) PT Raised to $80 at Stifel
- Best Crypto Presale: $0.0589 DigiTap Could Be the Price Retail Never Sees Again After Public Trading Starts
- Bitcoin Price Prediction: BTC Golden Cross Targets $90K as $2.64M Sits in AlphaPepe Before Price Discovery
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Stifel, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share